Schizophrenia In January, the Berlin-based psychedelics giant ATAI Life Sciences purchased a majority stake in Recogify – a company researching drugs to combat ailments associated with schizophrenia. The…
Latest News
Top 5 Gainers and Losers: KASH.CN, QIMC.CN, TGH.V
Zentek (ZTEK.V) took a years long path to figure out its incredible biotech potential
Tesla stock to $100?
Top 5 Gainers and Losers: KASH.CN, DHR.V, BRO.V
Standard Uranium (STND.V) looks to add to Sun Dog’s uranium history
Top 5 Gainers and Losers: SEI.V, LAB.V, NCU.TO